Torrent Pharmaceuticals Limited (NSE: TORNTPHARM)
India
· Delayed Price · Currency is INR
3,399.45
-20.90 (-0.61%)
Dec 24, 2024, 3:29 PM IST
Torrent Pharmaceuticals Revenue
Torrent Pharmaceuticals had revenue of 28.89B INR in the quarter ending September 30, 2024, with 8.61% growth. This brings the company's revenue in the last twelve months to 112.24B, up 9.68% year-over-year. In the fiscal year ending March 31, 2024, Torrent Pharmaceuticals had annual revenue of 107.28B with 11.51% growth.
Revenue (ttm)
112.24B
Revenue Growth
+9.68%
P/S Ratio
n/a
Revenue / Employee
7.14M
Employees
15,718
Market Cap
1,151.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 107.28B | 11.08B | 11.51% |
Mar 31, 2023 | 96.20B | 11.12B | 13.07% |
Mar 31, 2022 | 85.08B | 5.03B | 6.29% |
Mar 31, 2021 | 80.05B | 652.60M | 0.82% |
Mar 31, 2020 | 79.39B | 2.67B | 3.47% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTorrent Pharmaceuticals News
- 24 days ago - Pharma stocks weekly roundup: Biocon leads with 9.08% gain, Torrent Pharma up 4.91%, Lupin dips 1.82% - Business Upturn
- 26 days ago - Torrent Pharmaceuticals market cap rises Rs 3,450 crore - Business Upturn
- 4 weeks ago - Torrent Pharma receives EIR from USFDA for Pithampur facility - Business Upturn
- 4 weeks ago - Torrent Pharma shares rise nearly 3% after receiving EIR from USFDA - Business Upturn
- 2 months ago - Torrent Pharma Block Deal: 1.04 crore shares or 3% equity worth Rs 3,230 crore change hands - Business Upturn
- 2 months ago - Stock to watch today: Torrent Pharma promoter to sell up to 2.9% stake via block deal: Report - Business Upturn
- 2 months ago - Torrent Pharmaceuticals shares in focus as Q2 profit rises 17.4% to ₹453 crore - Business Upturn
- 3 months ago - Torrent counters faulty drug claim - The Times of India